Cas:13722-96-8 2,4-Dihydroxy-5-nitrobenzoic acid manufacturer & supplier

We serve Chemical Name:2,4-Dihydroxy-5-nitrobenzoic acid CAS:13722-96-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,4-Dihydroxy-5-nitrobenzoic acid

Chemical Name:2,4-Dihydroxy-5-nitrobenzoic acid
CAS.NO:13722-96-8
Synonyms:Benzoic acid,2,4-dihydroxy-5-nitro;4-Nitro-6-carboxy-resorcin;Benzoic acid, 2,4-dihydroxy-5-nitro-;2,4-Dihydroxy-5-nitro-benzoesaeure;5-Nitro-2,4-dihydroxy-benzoesaeure;2,4-Dihydroxy-5-nitrobenzoic acid;2,4-dihydroxy-5-nitro-benzoic acid
Molecular Formula:C7H5NO6
Molecular Weight:199.118
HS Code:2918290000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:474.0±30.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.715
PSA:123.58000
Exact Mass:199.011688
LogP:2.38

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzoic acid,2,4-dihydroxy-5-nitro chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4-dihydroxy-5-nitro-benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-Dihydroxy-5-nitro-benzoesaeure Use and application,2,4-dihydroxy-5-nitro-benzoic acid technical grade,usp/ep/jp grade.


Related News: I believe they came to the right decision on behalf of the American public, Sandrock said in an interview. 2,4-Dihydroxy-5-nitrobenzoic acid manufacturer I believe they came to the right decision on behalf of the American public, Sandrock said in an interview. 2,4-Dihydroxy-5-nitrobenzoic acid supplier Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2). 2,4-Dihydroxy-5-nitrobenzoic acid vendor When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant. 2,4-Dihydroxy-5-nitrobenzoic acid factory The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed.